Market Access Views & Analysis

Views & Analysis

Market Access

Interview at BIO 2025 with Kyle Touchstone and Laura Rowley

Biotech opportunities in North Carolina, with Kyle Touchston...

From BIO 2025: Kyle Touchstone, director of Economic Development Raleigh and Laura Rowley, director of life sciences development for NCBiotech.

Market Access

American flag waving with the Capitol Hill

Four months, 157 Executive Orders: Inside the science of Tru...

When Donald Trump returned to the White House in January 2025, the question wasn't whether his administration would change the direction of US health policy – it was how quickly, how deeply

Market Access

The changing landscape of drug clinical assessment: Tommy Br...

In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.

Market Access

BIO 2025: Makary: Drugs don’t have to take 10 years to get t...

FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply held assumptions”.

Market Access

Political uncertainties, tariffs, funding crunch? LSX World ...

The weather was hot in London for this year’s LSX World Congress – but what was the atmosphere like at Europe’s leading partnering, strategy, and investment event?

Market Access